Uphononongo olutsha luvavanya amandla eMasimo EMMA® Capnography ukuvavanya imeko yokuphefumla kubantwana beTracheostomy

I-Neuchatel, eSwitzerland--(I-WIRE YOSHISHINO)---Masimo (NASDAQ: MASI) namhlanje ibhengeze iziphumo zophononongo lokujonga i-retrospective olupapashwe kwi-International Journal of Pediatrics.Kolu phononongo, abaphandi kwisibhedlele sase-Osaka sabasetyhini kunye nabantwana eJapan bafumanise ukuba I-Masimo EMMA® i-capnometer ephathekayo "inokusetyenziswa ukuhlola imeko yokuphefumla yabantwana abaphantsi kwe-tracheotomy."1 I-EMMA® ifumaneka kwifom ehlangeneyo yezigulane zabo bonke ubudala I-capnograph engapheliyo engenamthungo, isixhobo ekulula ukusiphatha.Isixhobo sifuna akukho kulinganisa okuqhelekileyo, kunexesha elincinci lokufudumala, kwaye ibonisa i-carbon dioxide echanekileyo yokuphela kwe-tidal (EtCO2) kunye nemilinganiselo yokuphefumula kunye ne-EtCO2 waveform eqhubekayo ngaphakathi kwemizuzwana ye-15.
Ukuqaphela ixabiso elinokubakho lendlela edibeneyo kunye nephathekayo yokubeka esweni utshintsho kwimeko yokuphefumla yezigulane kwiimeko apho izixhobo eziqhelekileyo zokubeka iliso esibhedlele zingenakwenzeka ukuba zifumaneke, uDkt. Masashi Hotta kunye noogxa bafuna ukuvavanya ukusetyenziswa kwe-EMMA capnography kubantwana ngokuthelekisa. idatha evela kumaxabiso EtCO2 ukusuka isixhobo EMMA (encanyathiselwe ekupheleni distal kwityhubhu tracheostomy) kunye invasively umlinganiselo woxinzelelo lwevenous inxalenye carbon dioxide (PvCO2) for tracheotomy.Ngelixa inxenye yoxinzelelo lwentsimbi carbon dioxide (PaCO2) ithathwa igolide umgangatho wokuvavanya ubume bokuphefumla, abaphandi bakhetha i-PvCO2 kuba "ukuthatha iisampulu ze-arterial kuyingozi ngakumbi kunokuthatha iisampulu ze-venous," beqaphela ukuba izifundo zibonise ukuba i-PaCO2 kunye ne-PvCO2.2,3 Baqeshe iintsana eziyi-9 (iminyaka eyi-8 yeminyaka yobudala) kwaye bathelekisa a Iyonke ngama-43 ngamaqela ofundo lwe-EtCO2-PvCO2.
Abaphandi bafumene i-coefficient yokulungelelanisa phakathi kwe-EtCO2 kunye ne-PvCO2 yokufunda kwe-0.87 (i-95% yexesha lokuzithemba 0.7 - 0.93; p <0.001) Umda wesivumelwano se-% wawuyi-1.0 - 19.1 mmHg) .Abaphandi bacinga ukuba i-Trend for EtCO2 ibe ngaphantsi kwe-PvCO2 inokuchazwa "ngokuxuba igesi kufuphi nombhobho we-tracheostomy ngenxa yobukho bendawo yokufa ye-anatomical kunye ne-physiological. Ekubeni phantse zonke izigulane zisetyenzisiweyo iityhubhu ezingenazo iicuffs, oku kusenokuba kwenzekile Okunye ukuvuza.Kwaye, malunga nesibini kwisithathu sezigulane zine [isifo semiphunga esingapheliyo okanye i-bronchopulmonary dysplasia], eziye zabonisa ukuba zibonise igalelo kwi-CO2 ngexesha lokukhupha umoya xa kuthelekiswa noxinzelelo lwe-CO2 egazini Ukuxinana kwehle.
Baye bafumanisa ukuba ulwahlulo oluphakathi ekufundeni oluqokelelweyo ngelixa izigulane zifumana i-ventilation ye-mechanical yayinkulu kakhulu (i-28 ye-43 izibini zedatha). (p = 0.043) .Abaphandi baqaphele ukuba ukusetyenziswa kwe-ventilator kwakunxulunyaniswa kakhulu nokungafani kokufundwa okudibeneyo kuba izigulane kwii-ventilators zineemeko zokuphefumla okanye zokujikeleza.
"Sibonisa ubudlelwane obuhle obuqinileyo phakathi kwe-PvCO2 kunye ne-EtCO2 kwaye sityhila ukusetyenziswa kunye nokusetyenziswa kwe-capnometer kubantwana abaphantsi kwe-tracheotomy," abaphandi baphetha ngokuthi, "i-EMMA ingasetyenziselwa ukuvavanya imeko yokuphefumula yabantwana abaphantsi kwe-tracheotomy. I-EMMA iluncedo kakhulu kwi-tracheotomy. iindawo zokhathalelo lwasekhaya kunye nemeko yezigulane zangaphandle kubantwana abanjalo."Baphinde baqaphele, "Amandla aphambili kwesi sifundo kukuba sasebenzisa i-capnometer ephathekayo ukuvavanya i-EtCO2."
I-Masimo (NASDAQ: MASI) yinkampani yeteknoloji yezonyango yehlabathi ephuhlisa kwaye ivelise uluhlu olubanzi lwetekhnoloji yokubeka iliso ekhokelayo kwishishini, kubandakanywa imilinganiselo, izinzwa, iimonitha zezigulane, kunye nezisombululo ezizenzekelayo kunye nokudibanisa. Umsebenzi wethu kukuphucula isigulane. Iziphumo kunye nokunciphisa iindleko zokhathalelo.Yaziswa ngo-1995, i-Masimo SET® Measure-through Motion kunye ne-Low Perfusion™ pulse oximeter ibonise ukusebenza kwayo ngaphezu kobunye ubugcisa be-pulse oximeter kwizifundo ezingaphezu kwe-100 ezizimeleyo kunye nenjongo. iboniswe ukunceda oogqirha ukunciphisa i-retinopathy enzima kwiintsana zangaphambi kwexesha, i-5 iphucula ukuhlolwa kwe-CCHD kwiintsana ezisanda kuzalwa, i-6 kunye nokunciphisa iinzame zeqela lokuphendula ngokukhawuleza xa usebenzisa i-Masimo Patient SafetyNet™ ngokubeka iliso ngokuqhubekayo kwiwadi yasemva kokusebenza.Ukusebenza, ukudluliselwa kwe-ICU kunye neendleko.I-7-10 iqikelela ukuba i-Masimo SET® iya kusetyenziswa ngaphezu kwe-200 yezigidi zezigulane kwizibhedlele ezihamba phambili kunye nezinye izibonelelo zempilo emhlabeni jikelele, i-11 ngokutsho kwe-2020-21 US News & World Report Best Hospitals Honor I-Roll, i-11 kwaye yenye yezibhedlele eziphezulu ze-10 ze-9 eziphambili ze-pulse oximeters. I-Masimo iyaqhubeka nokuphucula i-SET®, kwaye kwi-2018 ibhengeze ukuba i-RD SET® sensor's SpO2 ukuchaneka phantsi kweemeko zokunyakaza kuye kwaphuculwa kakhulu, ukubonelela oogqirha ngokuzithemba okukhulu. Ixabiso le-SpO2 abathembele ngokuchanekileyo libonisa isimo somzimba wesigulana. Ngo-2005, uMasimo wazisa iteknoloji ye-rainbow® Pulse CO-Oximetry, eyenza ukuba i-non-invasive kunye neqhubekayo yokubeka iliso kwiinxalenye zegazi ngaphambili ilinganiswe ngokuhlaselayo kuphela, kuquka i-hemoglobin epheleleyo (SpHb®). ), isiqulatho seoksijini (i-SpOC™), i-carboxyhemoglobin (i-SpCO®), i-Methemoglobin (SpMet®), i-Pleth Variability Index (PVi®), i-RPVi™ (i-rainbow® PVi) kunye ne-Oxygen Reserve Index (ORi™).Ngo-2013, uMasimo usungule i-Root® Patient Monitoring and Connectivity Platform, eyakhiwe ukusuka phantsi ukuya phezulu ukuze ibe bhetyebhetye kwaye ibe nokwandiswa kangangoko ukuze kuququzelelwe ukongezwa kobunye ubugcisa bokubeka iliso beMasimo kunye nomntu wesithathu;izongezo eziphambili kuMasimo ziquka isizukulwana esilandelayo se-SedLine® Brain monitoring function, i-O3® yengingqi ye-oxygen saturation kunye ne-ISA™ capnography kunye ne-NomoLine® sampling line.Umgca we-Masimo oqhubekayo kunye nokuhlola indawo, i-Pulse CO-Oximeters®, iquka izixhobo ezenzelwe sebenzisa kwiimeko ezahlukeneyo zeklinikhi kunye nezingezizo ezeklinikhi, kubandakanywa iteknoloji yokunxiba engenazintambo ezifana neRadius-7® kunye neRadius PPG ™, izixhobo eziphathekayo ezifana neRad-67™, i-Fingertip pulse oximeters ezifana ne-MightySat® Rx kunye nezixhobo ezinokubakho. esetyenziswa esibhedlele nakwikhaya elifana neRad-97®.Masimo isibhedlele esizenzekelayo kunye nezisombululo zoqhagamshelo zigxile kwiqonga leMasimo Hospital Automation™ kwaye ziquka i-Iris® Gateway, iSirona™, Patient SafetyNet, Replica™, Halo ION™, UniView ™, UniView:60™ kunye neMasimo SafetyNet™.Ukufumana ulwazi oluthe vetshe malunga neMasimo kunye neemveliso zayo, tyelela www.masimo.com.Izifundo zeklinikhi ezipapashiweyo ngeemveliso zeMasimo zinokufumaneka ku-www.masimo.com/evidence/featured-studies/feature /.
I-ORi kunye ne-RPVi azikayifumani imvume ye-FDA 510(k) kwaye ayinakuthengiswa e-United States.I-trademark Patient SafetyNet isetyenziswa phantsi kwelayisensi evela kwi-University HealthSystem Consortium.
Olu shicilelo lweendaba lubandakanya iingxelo ezijonge phambili ngaphakathi kwentsingiselo yeCandelo le-27A yoMthetho we-Securities Act ka-1933 kunye neCandelo le-21E ye-Securities Exchange Act ye-1934 ngokubhekiselele kuMthetho woLungiso lwe-Private Securities Litigation we-1995.Ezi nkcazo ezijonge phambili zibandakanya: Ezinye , iinkcazo malunga nokusebenza okunokwenzeka kwe-EMMA®.Ezi nkcazo ezijonge phambili zisekelwe kwizinto ezilindelekileyo ngoku zeziganeko ezizayo ezisichaphazelayo kwaye zixhomekeke kwimingcipheko kunye nokungaqiniseki, konke kunzima ukuqikelela, uninzi lwazo olungaphaya kwamandla ethu kwaye lunokwazi. kubangela ukuba iziphumo zethu zokwenyani zihluke kwezo zibangelwa yimingcipheko eyahlukeneyo Izinto ezinegalelo kwiingozi esizibonisayo kwiingxelo zethu ezijonge phambili zibandakanya, kodwa azikhawulelwanga: iingozi ezinxulumene neengcinga zethu malunga nokuphindaphinda iziphumo zekliniki;enxulumene nenkolelo yethu yokuba itekhnoloji ye-Masimo ekhethekileyo yokulinganisa i-non-invasive, kubandakanywa i-EMMA, igalelo kwimingcipheko efanelekileyo yeklinikhi ehambelana neziphumo kunye nokhuseleko lwesigulane;imingcipheko eyayanyaniswa nenkolelo yethu yokuba impumelelo kaMasimo yonyango engangeneleliyo ibonelela ngezisombululo ezingabizi kakhulu kunye neenzuzo ezizodwa;imingcipheko eyayanyaniswa ne-COVID-19;kunye neefayili zethu kunye neKhomishoni yezoKhuseleko kunye noTshintshiselwano ("SEC") Izinto ezongezelelweyo ezixutyushwayo kwicandelo elithi "Izinto zoMngcipheko" kwingxelo yamva nje zifumaneka ngaphandle kwentlawulo kwiwebhusayithi ye-SEC kwi-www.sec.gov.Nangona sikholelwa ukuba ukulindela ezibonakaliswe kwiingxelo zethu ezijonge phambili zinengqiqo, asazi ukuba izinto esizilindeleyo ziya kungqineka zichanekile.Zonke iingxelo ezijonge phambili eziqulethwe kolu shicilelo lweendaba zicace gca ukuba zifanelekile ngokupheleleyo ngezi zilumkiso zingentla.Nceda ulumke ungaze beka ukuthembela ngokungafanelekanga kwezi nkcazo ezijonge phambili, ezithetha kuphela namhlanje.Asenzanga sibophelelo sokuhlaziya, ukuhlaziya okanye ukucacisa ezi nkcazo okanye "iMiciko yoMngcipheko" equlethwe kwingxelo yethu yamva nje kwi-SEC, nokuba kungenxa yolwazi olutsha. , iziganeko zexesha elizayo okanye ngenye indlela, ngaphandle kokuba kunokufuneka phantsi kwemithetho yokhuseleko esebenzayo.
Uphononongo olutsha lufumanisa ukuba iMasimo EMMA® Capnograph ingasetyenziselwa ukuvavanya ukuphefumla kubantwana abane-tracheostomy.

  • Ngaphambili:
  • Okulandelayo:

  • Ixesha lokuposa: Jun-20-2022